The North Chicago-based drug company announced a $350 million deal on March 3 to purchase Denmark-based biotech company Gubra and its weight loss medication, GUB014295, also known as Gubamy
Chaker L, Bianco AC, Jonklaas J, Peeters RP
To further ensure the safety of the drug, the clinical significance of this rise in calcitonin levels must be clarified in future tirzepatide trials
Liquid food supplement in cherry-cola flavour, containing L-carnitine and pantothenic acid for physically active adults
Astragaloside-IV loaded into lipid nanocapsules (ASIV-LNCs) could reach the retinal layer via topical eye drops to treat AMD, demonstrating the feasibility of delivering nanocapsule-encapsulated drugs to the retinal layer using eye drops [71]
Who else is on the OxyShred train